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Cardiovascular disease remains the most common cause of
mortality in patients with end-stage kidney disease treated
by regular hemodialysis. To improve blood pressure control
and reduce cardiovascular risk, the United Kingdom Renal
Association standards committee introduced pre- and post-
dialysis target blood pressures of less than 140/90 and 130/
80 mm Hg, respectively. We audited blood pressure control
and symptomatic intradialytic hypotension requiring fluid
resuscitation in the Greater London area renal centers that
serve 2630 patients. The study captured 7890 hemodialysis
sessions during a 1-week period where only 36% of the
patients achieved the pre-dialysis target and 42% the post-
dialysis target, with a wide variation between centers.
Different antihypertensive medication prescriptions did not
affect achievement of these targets. Fifteen percent of the
patients suffered symptomatic hypotension requiring fluid
resuscitation associated with significantly greater
interdialytic weight gains. Our study found that intradialytic
hypotension was significantly greater in centers that
achieved better post-dialysis blood pressure targeting.
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Hypertension and cardiovascular risk in the general
population
In the general population, there is a strong association
between hypertension and death and, in particular, increasing
pulse pressure as a result of decreased conduit artery
compliance.1 The relative risk of hypertension for stroke
and heart attack is greatest for younger subjects, although the
absolute risk increases with age. In addition to stroke and
heart attack, hypertension is also causally linked with heart
failure and chronic kidney disease. A nonlinear association or
‘J’-shaped curve has been reported between blood pressure
and recurrent events in patients with previous myocardial
infarction. Despite concerns that this increased risk may have
been attributable to an adverse effect of treatment, it is now
considered more likely to reflect the severity of disease on
blood pressure—the larger the size of myocardial infarction,
the greater the fall in blood pressure—rather than the effect
of blood pressure or its treatment on the disease.2
Hypertension has been defined by the US Joint National
Committee on Prevention, Detection, Evaluation and Treat-
ment of High Blood Pressure3 (Table 1).
Hypertension and cardiovascular risk in the chronic kidney
disease population
Cardiovascular death remains the most common cause of
death in the chronic hemodialysis population, however; the
same strong association is not seen with hypertension.4 For
example, systolic hypertension in Japanese hemodialysis
patients was not associated with any excess heart attacks
and/or stroke, although there was an increased risk of
intracranial hemorrhage with systolic blood pressures
4180 mm Hg.5 In addition, post-mortem studies have
shown that lacunar infarcts secondary to hypertension were
the most common finding, even in patients without overt
cerebrovascular disease.6
Blood pressure targets in the chronic kidney disease
population
In view of the risk of cardiovascular death in hemodialysis
patients, blood pressure control has become a major target
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for intervention. As with the general population, there is a
‘J’-shaped relationship with increased mortality in both those
with the highest and lowest blood pressure.7 This may be the
consequence of prolonged sustained hypertension, resulting
in cardiac damage, and eventually cardiac failure, associated
with a low blood pressure8 and increased mortality.
Although there has been no adequately powered inter-
vention to study the potential benefit of blood pressure
control in hemodialysis patients, standards committees have
introduced blood pressure targets for dialysis patients. In the
United Kingdom, the Renal Association standards committee
produced a document in 2002 that stated that hemodialysis
patients with chronic kidney disease stage V should have
pre- and post-dialysis blood pressures of o140/90 and
o130/80 mm Hg, respectively.9 These targets were stricter
than in the previous version, based on the absolute benefits of
blood pressure control being greater in those patients with a
high pulse pressure and non-compliant vasculature.10
Purpose of audit
To determine whether these targets were achievable in clinical
practice and also whether the lower pre-dialysis blood
pressure targets resulted in increased intradialytic hypo-
tension, we prospectively audited blood pressure in a cohort
of thrice weekly chronic hemodialysis patients attending
dialysis centers in the Greater London area.
RESULTS
The first part of the audit was designed to assess how many
patients achieved the UK Renal Association targets of pre-
and post-dialysis blood pressures of o140/90 and o130/
80 mm Hg, respectively. A total of 2630 patient pro formas
were completed and returned for the audit, capturing 7890
hemodialysis sessions. The number of patients dialysing in
the 11 centers ranged from 91 to 408, with median of 244
patients. The average pre-dialysis blood pressure recorded
before the three dialysis sessions was 146.9±23.6/
88.2±13.1 mm Hg. The pre-dialysis blood pressure standard
was achieved in 36% of all patients. This varied between the
11 hospital centers, ranging from 28 to 57% (Figure 1). The
average post-dialysis blood pressure was 134.5±28.2/
72.3±12.8 mm Hg, and 42% of all patients achieved the
post-dialysis standard of o130/80 mm Hg, with a range of
32–51% (Figure 1). Only 26% of all patients met both
standards, ranging from 19 to 45% between the 11 hospital
centers. There was an inverse relationship between the size
of the center and the percentage of patients achieving the
pre-dialysis target blood pressure, with smaller centers having
greater success, r¼0.71, P¼ 0.018, but there was no
correlation between center size and achievement of post-
dialysis blood pressure and/or both targets.
Seventy percent of all patients were prescribed antihyper-
tensives, whether as blood pressure control or as cardio-
protective agents. This ranged from 49 to 94% of patients
between centers. On average, 57% of patients were instructed
not to take their antihypertensive medications before
hemodialysis, although this practice varied markedly between
hospitals, ranging from 0 to 100%.
There was no correlation between the percentage of
patients taking antihypertensive medications in centers and
the percentage of patients achieving the pre-dialysis blood
pressure target, r¼0.16, P¼ 0.6 and/or both targets,
r¼0.44, P¼ 0.17. There was a direct correlation between
the percentage of patients in a center not prescribed
antihypertensives and that center achieving the post-dialysis
target blood pressure (Figure 2).
Of those prescribed antihypertensive agents, angiotensin-
converting enzyme inhibitors (ACEIs) and/or angiotensin
receptor blockers (ARBs) were the most commonly pre-
scribed, with 42% of all patients prescribed these medica-
tions, and ranging from 28 to 76% patients between centers.
b-Blockers were the next most commonly prescribed
antihypertensive agents, 27% (ranging between 15 and 47%
between the centers). There was no difference in achieving
either pre-dialysis blood pressure targets, in those patients
prescribed ACEIs/ARBs compared to other antihypertensives,
18 vs 10%, respectively (w2¼ 2.29, P40.1), or post-dialysis
target, 20 vs 13%, respectively (w2¼ 0.43, P¼ 0.5), and both
targets, 11 vs 6%. In addition, there was no significant
difference in achieving either the pre-dialysis blood pressure
target, whether patients were prescribed antihypertensive
medication, or not (Figure 3).
There was no difference in the number of patients selected
to be on the cadaveric renal transplant waiting list achieving
either the pre-dialysis blood pressure target, 40% compared
Table 1 | JNC-VII classification of blood pressure in adults3
Category
Systolic blood
pressure (mm Hg)
Diastolic blood
pressure (mm Hg)
Normal o120 and o80
Prehypertension 120–139 or 80–89
Hypertension stage 1 140–159 or 90–99
Hypertension stage 2 X160 X100
JNC-VII, Joint National Committee-VII.
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Figure 1 | Percentage of patients in each of the 11 hospital
dialysis centers achieving pre- and post-dialysis UK
Renal Association blood pressure targets of o140/90 and
o130/80 mm Hg, respectively.
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to 35% not on the waiting list, or the post-dialysis target, 45
vs 40%, respectively.
There was no difference between ethnic groups in terms of
achieving the UK Renal Association blood pressure targets,
with 39% of Caucasian, 33% black, 33% Asian, and 33% of
other races achieving the pre-dialysis standard, and 43%
Caucasian, 41% black, 41% Asian, and 41% of other races
achieving the post-dialysis target. Although more patients
from ethnic minorities were prescribed antihypertensive
medication, including 74% of blacks, 73% of Asians, 73%
for other races, and 66% Caucasians, there was no statistical
difference in blood pressure control between ethnic groups.
There was a very weak correlation between interdialytic
weight gain for all patients and pre-dialysis blood pressure,
r¼ 0.1, Po0.01, but not post-dialysis blood pressure.
Similarly, there was a weak correlation between dialysate
sodium concentration and pre-dialysis systolic blood pres-
sure, r¼ 0.032, Po0.05. There was a direct correlation
between dialysate sodium concentration and interdialytic
weight gain, r¼ 0.137, Po0.01. However, there was an
unexpected correlation between dialysate sodium concentra-
tion and the post-dialysis blood pressure, r¼0.56, Po0.01,
and this may have been due to clinicians trying to sustain
blood pressure in severely hypotensive patients by deliber-
ately increasing the dialysate sodium.
Hypotension during dialysis requiring intravenous fluid
resuscitation was recorded in 7% of all hemodialysis sessions,
which varied from 4 to 13% between centers. Overall, some
15% of patients experienced at least one hypotensive episode
over the three dialysis sessions and 2% of patients suffered
hypotensive episodes during each of the three dialysis
sessions. The incidence of persistent clinically symptomatic
intradialytic hypotension, requiring intravenous fluid resus-
citation, varied from 0 to 4% between centers. There was a
correlation between the percentage of patients achieving the
post-dialysis blood pressure standard in a center and the
percentage of symptomatic intradialytic hypotensive episodes
requiring intravenous fluid resuscitation, r¼ 0.81, P¼ 0.003
(Figure 4), but there was no correlation between intradialytic
hypotension and achievement of the pre-dialysis blood
pressure target, r¼0.12, P¼ 0.71.
Patients were more likely to suffer clinically symptomatic
hypotensive episodes requiring intravenous fluid resuscita-
tion if they were not prescribed antihypertensives, 21%
compared to 13% of those prescribed antihypertensives,
(w2¼ 20.2, Po0.001). This apparent difference could have
been potentially exaggerated, as patients prone to intradia-
lytic hypotension prescribed antihypertensive medications
may have been advised to withhold their antihypertensives
before dialysis. The advice regarding taking prescribed
antihypertensive medication varied from center to center,
with 57% of patients advised not to take their medication
before dialysis, but this advice varied from 0 to 100%
between centers. Eleven percent of patients who omitted their
antihypertensives before dialysis suffered one or more
hypotensive episodes compared to 7% of those who took
their medication (w2¼ 0.58, P¼ 0.44). There was no
significant difference between the incidence of recorded
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Figure 2 | Relationship between the percentage of patients not
prescribed antihypertensive medications in each of the 11
dialysis centers and percentage of patients in that center
achieving the pre- and post-dialysis UK Renal Association blood
pressure targets.
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Figure 3 | Percentage of all hemodialysis patients audited
achieving the pre-, post-dialysis, and both UK Renal Association
blood pressure targets, whether they were prescribed
antihypertensive medications or not.
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Figure 4 | Relationship between the percentage of patients
achieving the UK Renal Association post-dialysis blood pressure
target in each of the 11 dialysis centers and the percentage of
dialysis patients with clinically symptomatic intradialytic
hypotension requiring intravenous fluid resuscitation in that
center.
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hypotensive episodes and drug prescription; 23.1% of
patients prescribed a-blocker monotherapy, 15.6% calcium
channel blockers, 20.7% b-blockers, and 16.9% prescribed
ACEIs/ARBs (Figure 5).
Patients who developed clinically symptomatic intradia-
lytic hypotension requiring intravenous fluid resuscitation
had greater median interdialytic weight gains as both
absolute weight gain, 2.42 kg (1.8–3.0 ) vs 2.1 kg (1.3–2.8),
Po0.01 and percentage increase compared to target dry
weight, median 3.2% (2.4–4.3) vs 2.8% (1.8–3.9), Po0.0001.
Those patients who suffered clinically symptomatic
intradialytic hypotension had a lower pre-dialysis mean
diastolic pressure, median 75 mm Hg (66–85) compared to
those who did not, median 78 mm Hg (69–88), Po0.001. In
addition, hypotensive-prone patients were also noted to have
a lower pulse pressure, 64 mm Hg (50–81) vs 68 mm Hg
(54–81), Po0.01.
DISCUSSION
Whereas in the general population there is a strong causal
association between hypertension and both cardiovascular
morbidity and mortality, the association is less clear in
hemodialysis patients. Some studies have reported that
although hypertension was not associated with early
mortality of hemodialysis patients, it did have a later effect
when systolic blood pressure was 4160/90 mm Hg,8 whereas
other studies have reported increased mortality only when
the systolic pressure is greater than 180 mm Hg.11 A review of
the US renal database reported that a low pre-dialysis systolic
blood pressure was associated with increased risk of
mortality, but there was no increased mortality risk with
systolic hypertension, although there was an increased risk of
stroke.7 Similarly, the Japanese renal registry does show an
increased risk of cerebral hemorrhage in patients with both
pre- and post-dialysis hypertension.5 However, post-dialysis
systolic blood pressure has been associated with an elevated
mortality risk both for low and high levels as compared with
mid-range blood pressures.7
Compliance with blood pressure targets
In this audit of 2630 established thrice weekly hemodialysis
patients, only 36% achieved the UK Renal Association pre-
dialysis blood pressure target of o140/90 mm Hg, 42% the
post-dialysis standard of o130/80 mm Hg, and 26% met
both standards. The percentage of patients achieving the
targets varied between the 11 centers, ranging from 28 to 57%
for pre-dialysis and 32 to 51% for post-dialysis targets. The
pre-dialysis target blood pressure was more readily achieved
in those centers with the smaller hemodialysis program,
although program size had no effect on achieving either the
post-dialysis target and/or both blood pressure targets.
Differences in clinical practice between centers
There was tremendous variation in clinical practice between
the centers, in terms of the prescription of antihypertensive
medications, varying from 49 to 94%. Those centers with the
highest rate of prescription of antihypertensive medications
did not dialyse their patients against significantly higher
dialysate sodium concentrations. There was no correlation
between the centers in terms of prescription of antihyper-
tensive medications and achieving the pre-dialysis blood
pressure targets. Whether dialysis centers advised patients to
take their antihypertensives before attending for dialysis
had no effect on centers achieving the pre-dialysis blood
pressure target.
Achieving the pre-dialysis blood pressure target may
reflect differences in clinical practice as to whether clinicians
were more concerned in controlling post-dialysis blood
pressure rather than pre-dialysis blood pressure, as there has
been great debate as to which blood pressure recording more
accurately reflects the interdialytic blood pressure.12 Thus,
when targets are set, there are two key points: firstly, the
validity of the target, in terms of evidence base, and secondly,
the achievability of the target.9 Probably because of the lack
of strong evidence linking pre-dialysis hypertension and
mortality, this target was achieved only in 36% of patients.
Although there is greater evidence for an effect of post-
dialysis blood pressure on mortality, again this was achieved
in only 42% of patients. There was a direct correlation
between the percentage of patients not prescribed antihy-
pertensive medication in a center and achievement of the
target blood pressure by the center. This suggests that other
factors play a key role in determining blood pressure in
hemodialysis patients, for example, interdialytic weight gains
and dialysate sodium.13 In this audit, there was a direct
correlation between both interdialytic weight gain and
dialysate sodium concentration and the pre-dialysis systolic
blood pressure.
Achieving the blood pressure targets was not influenced by
the choice of antihypertensive medication, although margin-
ally more patients achieved the target blood pressures when
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Figure 5 | The effect of different drug classes on clinically
symptomatic intradialytic hypotension. Percentage of patients
developing intradialytic hypotension prescribed a-blockers, calcium
channel antagonists (Ca channel), b-blockers, and angiotensin-
converting enzyme inhibitors and/or angiotensin receptor blockers
(ACEI/ARBs) as monotherapy, and also those who were prescribed no
antihypertensive medications (none).
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prescribed ACEIs/ARBs, but this was not statistically
significant compared to other antihypertensives.
Blood pressure control was no different between those
patients selected for the renal transplant waiting list and for
those deemed medically unsuitable for transplantation.
Similarly, although a greater percentage of patients from
the ethnic minorities were prescribed antihypertensive
medications, blood pressure control was similar between
Caucasians and other ethnic groups. Thus, there were no
biases in how patients were treated.
Incidence of clinically significant intradialytic hypotension
requiring intravenous fluid resuscitation
The second purpose of the audit was to determine whether
the setting of more rigorous pre- and post-dialysis blood
pressure targets led to increased intradialytic hypotension.14
More recently, it has been shown that mortality is increased
in those hemodialysis patients prone to intradialytic
hypotension.15 Cohort studies have reported an incidence
varying from 6 to 27%, but the definition has often varied
from study to study.16 In this audit, we recorded hypotensive
episodes requiring intravenous fluid resuscitation. Fifteen
percent of patients suffered at least one interdialytic episode
of hypotension and 43 patients (2%) experienced hypoten-
sion during all three dialysis sessions. By taking a strict
definition of including only those hypotensive episodes
requiring active intervention, the potential number of
patients who suffered intradialytic hypotension would have
been much greater, using the newly published European Best
Practice Guidelines, which conform with the proposed
K/DOQI definition of a fall in systolic blood pressure
of X20 mm Hg, or lesser in mean arterial pressure of
10 mm Hg, associated with clinical events and need for
nursing intervention.16 Not only may intradialytic hypoten-
sion lead to a reduction and compromise in coronary artery
and cerebral perfusion pressure, but also hypotension
requiring intervention, by stopping ultrafiltration, is likely
to result in failure to achieve the desired target or dry weight,
thus leading to hypervolemia in the subsequent interdialytic
period.
The incidence of clinically symptomatic intradialytic
hypotension varied from center to center from 7 to 28% of
patients. This was not associated with the size of the dialysis
program, but was more common in those centers that had
greater achievement of the post-dialysis blood pressure
target. The question arises as to whether the increased
incidence of hypotension was driven by trying to achieve the
post-dialysis blood pressure goal. It is therefore important
that clinical recommendations and/or targets are based on
sound evidence and that if substantive proof is lacking, then
potential adverse events are fully recognized.
As expected from previous studies, the incidence of
hypotension was associated with greater absolute and
percentage interdialytic weight gains.16,17 In those patients
prescribed antihypertensive agents, whether patients took
their medications before dialysis or not had no impact on the
frequency of intradialytic hypotension, and similarly for
those prescribed a single antihypertensive agent, there were no
differences between ACEIs/ARBs, b-blockers, calcium channel
blockers, and a-blockers. Patients who suffered intradialytic
hypotension had lower pre-dialysis blood pressure, with a lower
pulse pressure, and were more likely not to be prescribed
antihypertensive agents. This is in keeping with previous reports
of increased morbidity and mortality in hemodialysis patients
with a low blood pressure.7,11
Summary
In this audit of hemodialysis patients, the number of patients
achieving the more rigorous UK Renal Association guideline
pre- and post-dialysis blood pressure targets was 36 and 42%,
respectively, with only 26% achieving both targets, suggesting
that blood pressure control needs to be improved. There was
a wide variation between dialysis centers, suggesting that
clinical practice plays an important role in determining blood
pressure control in dialysis patients. Interestingly, the
variation between the dialysis centers in terms of prescription
of antihypertensive medication did not have any measurable
effect on achieving blood pressure targets. One potential side
effect of rigorous blood pressure targets is an increase in
symptomatic intradialytic hypotension requiring intravenous
fluid resuscitation. In this audit, 7% of all treatments were
complicated by symptomatic hypotension. This was more
common in patients with large interdialytic weight gains and
more likely in those with lower pre-dialysis blood pressures
and pulse pressures. Intradialytic hypotension was not made
worse by the prescription of antihypertensive agents and
similarly was not affected whether patients took or abstained
from their medication before dialysis.
This audit raises the question as to whether the
introduction of strict pre- and post-dialysis blood pressure
targets for hemodialysis patients is beneficial, as evidence is
currently lacking as to the survival benefit of such strict
targets and any potential benefit may be obviated if attempts
to achieve the target result in increased symptomatic
intradialytic hypotension.
MATERIALS AND METHODS
The project was initiated by the London Renal Modernization Audit
Group and implemented by the Audit, Information and Analysis
Unit. Participation approval was obtained from each center’s Trust
and data protection policies were followed. Data were prospectively
collected during a 7-day period in September 2004 from adult
hemodialysis patients who had been dialysing thrice weekly for 490
days, in 13 main hospitals and 30 satellite dialysis units, located in
the Greater London area. Patients dialysing for 90 days or less were
excluded on the basis that they may still not have achieved their
appropriate target weight, and similarly patients dialysing twice
weekly or less were also excluded, as these patients may potentially
have had significant residual renal function.
Patient demographics
Data were collected on 2628 chronic dialysis patients, 1180 main
hospitals, and 1448 satellite dialysis patients. The majority of
Kidney International (2008) 73, 759–764 763
A Davenport et al.: Blood pressure control and intradialytic hypotension o r i g i n a l a r t i c l e
patients were male (60.5%) and Caucasian (49%), with 24%
classified as from the Asian subcontinent and 23% black. The
median age for the group was 61.2 years (interquartile range
46.9–72.3 years) but varied from 56.2 years (44.7–67.9) to 67.4 years
(56.3–78.3). Overall, 32% of all patients were diabetic and this
ranged from 21 to 37% between the 11 main renal units. However,
44% of Asian patients were diabetic, compared to 35% of blacks and
25% of Caucasian and other patients.
The majority of patients dialysed with an arteriovenous fistula
(60%) and 31% used tunneled central venous access catheters. All
patients used bicarbonate dialysate and polysulfone membrane
dialyzers; apart from two centers that used modified cellulose
acetate, the modal dialysis time was 4 h. Dialysate sodium
concentrations varied within centers, and most centers dialysed
patients prone to hypotension with cooled dialysate.
Blood pressure was routinely measured electronically in all units,
although in 2% of cases a mercury sphygmomanometer was used.
Blood pressure and weight were recorded pre- and post-dialysis in
each of the three dialysis sessions. Intradialytic hypotension was
defined as a sudden decrease in blood pressure that required
intravenous fluid replacement to restore the blood pressure.
Statistical analysis was by Student’s t-test, Mann–Whitney U-test,
w2-test, and either Pearson’s or Spearman’s correlation analysis. Data
are expressed as mean±s.d. or median and interquartile range.
Statistical significance was taken at or below the 5% level.
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